Projects per year
Personal profile
Personal profile
Dr. Butler graduated from Georgetown University School of Medicine in Washington, D.C. in 1982. He started his residency at Wilford Hall USAF Medical Center in San Antonio, Texas in 1982 and then completed his residency as Chief Resident at Stanford University Medical Center in 1986. After completing his postdoctoral training in 1987, Dr. Butler returned to the Wilford Hall USAF Medical Center where he became both the Chief of Radiation Oncology and the Chief of Brachytherapy. He also joined the faculty at The University of Texas Health Science Center at San Antonio as a Clinical Assistant Professor that same year. Dr. Butler would later join the Baylor College of Medicine where he would eventually become a full professor and the Chief of Radiation Oncology for both the medical school and the VA Hospital. He became the Medical Director of Radiation Oncology at Methodist in 1991, and received his faculty appointment at the Weill Medical School in 2006. He became Chair of Radiation Oncology at Houston Methodist in 2008. In 2016, Dr. Butler was named the Jim and Joan Harrell Chair in Radiation Oncology.
Research interests
Dr. Butler’s research centers on preclinical and clinical studies that combine radiation therapy and gene therapy for the treatment of prostate cancer. In recent years, he has extended these successful studies to other cancers, notably pancreatic cancer. His research interests also include three-dimensional reconstruction of body organs to assist in better localization of radiation therapy.
Education/Academic qualification
Radiation Therapy, Residency, Stanford School of Medicine
Jul 1 1984 → Jun 30 1987
Award Date: Jun 30 1987
MD, Georgetown University
… → May 31 1982
Award Date: May 31 1982
Research Area Keywords
- Imaging & Radiology
- Cancer
- Clinical Care
Free-text keywords
- Prostate cancer
- Pancreatic cancer
- Radiation therapy
- Gene therapy
- Computer visualization techniques
Fingerprint
- 1 Similar Profiles
Network
-
Phase I-II Study Evaluating HSV-tk + Valacyclovir Gene Therapy
Baskin, D. S., Butler, E. B. & Teh, B. S.
1/15/18 → …
Project: Clinical Trial
-
A Randomized Phase II Trial of Radiation Therapy and Cisplatin Alone or in Combination withIntravenous Triapine in Women with Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVACancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer.
Zaid, T., Butler, E. B., Darcourt, J., Farach, A. M., Kamat, A. A., Shkedy, C., Singh, M. & Suri, A.
3/1/14 → 2/28/39
Project: Non Profit
-
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative
Niravath, P. A., Bernicker, E. H., Butler, E. B., Chang, J. C., Farach, A. M., Haque, W. M., Heyne, K., Morgan, P. B., Shkedy, C. & Teh, B. S.
Project: Clinical Trial
-
A feasibility study of utilizing a cadaveric training model for novel robotic bladder cancer brachytherapy techniques
Patel, A., Orakwue, C. W., Olek, D., Guzman, J. C. A., Lim, K., Pino, R., Teh, B. S., Butler, B., Satkunasivam, R. & Farach, A., Mar 1 2023, In: Brachytherapy. 22, 2, p. 195-198 4 p.Research output: Contribution to journal › Article › peer-review
-
Prognostic Effect of Systemic Therapy and Radiation Therapy in Stage I Nodal Marginal Zone Lymphoma
Chevli, N., Margolis, V., Haque, W., Pingali, S. R., Butler, E. B. & Teh, B. S., Jan 1 2023, In: Practical Radiation Oncology. 13, 1, p. e80-e93Research output: Contribution to journal › Article › peer-review
-
Prognostic impact of biologically equivalent dose in stereotactic body radiotherapy for renal cancer
Tran, K. T., Chevli, N. C., Messer, J. A., Haque, W., Farach, A. M., Satkunasivam, R., Zhang, J., Darcourt, J., Lo, S. S., Siva, S., Butler, E. B. & Teh, B. S., Mar 2023, In: Clinical and Translational Radiation Oncology. 39, 100592.Research output: Contribution to journal › Article › peer-review
Open Access -
Role of 21-Gene Recurrence Score in Predicting Prognostic Benefit of Radiation Therapy After Breast-Conserving Surgery for T1N0 Breast Cancer
Chevli, N., Haque, W., Tran, K. T., Farach, A. M., Schwartz, M. R., Hatch, S. S., Butler, E. B. & Teh, B. S., May 1 2023, In: Practical Radiation Oncology. 13, 3, p. e230-e238Research output: Contribution to journal › Article › peer-review
Open Access -
21-Gene recurrence score predictive for prognostic benefit of radiotherapy in patients age ≥ 70 with T1N0 ER/PR + HER2- breast cancer treated with breast conserving surgery and endocrine therapy
Chevli, N., Haque, W., Tran, K. T., Farach, A. M., Schwartz, M. R., Hatch, S. S., Butler, E. B. & Teh, B. S., Sep 2022, In: Radiotherapy and Oncology. 174, p. 37-43 7 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations